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ABSTRACT Plasmid clones containing up to 94 kilobases 
of single-copy DNA from band q22.3 of chromosome 21 and a 
complete pool of insert DNA from a chromosome 21 recombi-
nant Iibrary have been used to rapidly detect numerical and 
structural aberrations of chromosome 21 by in situ hybridiza-
tion in both metaphase and interphase ceUs. A trisomie 
karyotype, diagnostic ofDown syndrome, is readily detected in 
nonmitotic cells because the majority of their nuclei exhibit 
three discrete fQCi of hybridization, in contrast to normal 
diploid cells, which show two foci. Chromosomal translQCations 
involving chromosome 21 sequences were also detected with 
these probes, and the intranuclear IQCation of 21q22.3 DNA 
sequences in "nontllll" human brain neurons was established 
with the plasmid DNA probe set. These results suggest that 
chromosome 21-specific probes may have utility in c1inical 
diagnostics, especially by facilitating the direct an~ysis of 
interphase cells. 
The smallest human autosome, chromosome 21, has been 
highly relevant to clinical cytogeneticists because trisomy 21 
is the primary cause of Down syndrome (1). The recent 
mapping of the locus for familial Alzheimer disease (2) and 
the gene for the amyloid ß protein (3, 4) to 21qll.2~21q21 
has focused additional attention on chromosome 21. Inter-
estingly, Down syndrome patients and familial Alzheimer 
patients both develop clinical dementias and have similar 
brain pathology with plaques rich in the amyloid ß protein (5, 
6). Cytogenetic studies have indicated that only trisomy of 
subregion 2iq22~21qter is required to elicit the Down 
syndrome phenotype. Ther!! is, however, so me disagreement 
as to which part of this subregion is responsible für the 
complex pathological effects (reviewed in ref. 7). 
The majority of Down syndrome patients (""'95%) show 
three chromosomes 21, and in about 5% of the cases, the 
trisomy is caused by a Robertsonian translocation (8). Both 
forms of trisomy are routinely diagnosed by conventional 
banding techniques Additionally, a small portion «<1%) of 
Down syndrome is caused by reciprocal translocation (8). 
This is difficult to diagnose because the translocated terminal 
segment of chromosome 21 can be very smalI, and it is 
detectable only by high-resolution banding. Another diag-
nostic complication is the occurrence of trisomy 21 mosai-
cism. It has been reported that the incidence of chromosome 
21 mosaicism is between 1% and 2%, although the actual 
frequency may be higher (8). 
Recent studies (9-15) have shown that the DNA of each 
chromosome occupies a discrete focal territory within an 
interphase nuc1eus. These observations indicate that chro-
mosomal aberrations can be detected directly in nonmitotic 
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cells by in situ hybridization using chromosome-specific 
probes. Indeed, a successful diagnosis oftrisomy 18 has been 
reported by using amniotic fluid cells hybndized with a 
repetitive sequence probe that, under high stringency con-
ditions, is specific for the centromeric region of chromosome 
18 (16). A similar diagnosis of trisomy 21 also has been 
reported (17) with probe DNA that was derived from flow-
sorted chromosome 21 but was not further defined. 
DNA probe sets that specifically label the terminal band 
21q22.3 or decorate the entire chromosome 21 are reported 
here, and the application of these prob!!s to the detection of 
numerical and structural aberrations of chromosome 21 in 
both metaphase and interphase cells is described. 
MATERIALS AND METHODS 
DNA Probes. All plasmids contain inserts of human chro-
mosome 21 that were mapped to 21q22.3 (18-22). All inserts 
were either known (20, 23-25) or verified by Southem blot 
analysis to be single-copy DNA; the plasmids other than pS2 
are subc10nes derived from a A phage Iibrary (24) or a cosmid 
Iibrary (25). The plasmids are Iisted in Table 1 with the 
Human Gene Mapping Workshop symbols (26) and the 
approximate insert fragment length. 
The human chromosome 21 genomic Iibrary LL21NS02 
was obtained from the American Type Culture Collection aQd 
amplified on agar plates as recommended. Phage DNA was 
prepared and digested with HindIll, and th!! DNA inserts 
were separated from the vector arms l:>Y preparative gel 
electrophoresis in 0.6% agarose. DNA was isolated from gel 
slices by electroelution; purified by Elutip-d chromatography 
(Schleicher & Schuell); extracted with phenol/chloroforqt, 1: 
1 (vol/vol); and precipitated with ethanol (14). 
Human Cells. Metaphase spreads and interphase nuc1ei 
were prepared from (i) lymphocyte cultures of normal (46, 
XV) individ~als, (ii) lymphocytes of Down syndrome 
(47,+21) individuals, (iii) chorionic villi sampies cultured for 
prenatal diagnosis (ii and iii were provided by T. Yang-Feng, 
Yale University Cytogenetics Laboratory), and (iv) cultures 
of TC620, an oligodendroglioma-derived pseudotriploid cell 
lim: (28). Standard techniques of colcemid treatment, hypo-
tonic treatment, and methanol/acetic acid fixation were 
used. Biopsy material from the cortical region of a "normal" 
human brain (46, XX) was fixed, sectioned, and permeabi-
lized as described (29). 
In Situ Hybridization. Various combinations of plasmid 
DNA, labeled with biotin-ll-dUTP by nick-translation (30), 
were used for hybridization at concentrations ranging from 2 
to 15 JLgjml depending on the pool size. For example, 15 
JLgjml was used when the probe mixture contained 94 
kilobases (kb) of insert DNA; the probe concentration was 
Abbreviations: CISS, chromosomal in situ suppression; CV, chori-
onic villi; DAPI, 4' ,6-diamidino-2-phenylindole. 
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Table 1. Plasmids with inserts from chromosome 21 
Gene 
symbol 
BCEI 
D2IS3 
D2IS23 
D2IS53 
D2IS55 
D2IS56 
Plasmid 
pS2 (23) 
pPW231F 
pPW231G 
pPW244D 
pPW512-6B 
pPW512-8B 
pPW512-lH 
pPW512-16P 
pPW512-18P 
pPW512-4R 
pPW512-12R 
pPW518-4H 
pPW518-10P 
pPW518-5R 
pPW520-5B 
pPW520-6B 
Insert 
length, 
kb 
0.6 
0.8*t 
0.7*t 
1.0 
3.0* 
3.8 
2.9*t 
2.7* 
1.6* 
4.7 
2.0* 
1.6* 
2.9* 
5.2*t 
5.0 
1.0* 
Gene 
symbol 
D21S56 
D2IS57 
D2IS64 
D2IS71 
Plasmid 
pPW520-10R 
pPW520-11R 
pPW523-10B 
pPW523-lH 
pPW523-5R 
pPW523-10R 
pPW523-19R 
pPW551-8P 
pPW551-12P 
pPW519-10P 
pPW519-11P 
pPW519-1R 
pPW519-8R 
pPW519-9R 
pPW519-14R 
pPW519-22R 
Insert 
length, 
kb 
4.6*t 
1.8*t 
6.5* 
7.0* 
2.2*t 
3.8*t 
2.5* 
1.9* 
4.2* 
0.8 
3.0 
6.0* 
2.9*t 
1.7* 
4.0*t 
1.8* 
Preparation of plasmid DNA was according to standard protocols 
(27). Various probe sets were obtained by pooling plasmids (equal 
molar amounts), resulting in DNA probe complexities of 94 kb (all 
plasmids Iisted), 75 kb (plasmids labeled with an asterisk), or 29 kb 
(plasmids labeled with a dagger). 
decreased in proportion to the sequence complexity of the 
probe mixture. The size ofthe probe DNA was adjusted to a 
length of 150-250 nucleotides empirically by varying the 
DNase concentration in the nick-translation reaction. The 
hybridization cocktail also contained 50% formamide, 0.30 M 
NaCl, 0.03 M sodium citrate (pH 7), 10% (wt/vol) dextran 
sulfate, and on occasion 0.5 mg of sonicated salmon sperm 
DNA per ml. Simultaneous denaturation of probe and target 
DNA was carried out at 75°C for 6 min (metaphase spreads) 
or 94°C for 11 min (tissue slices). Hybridization reactions 
were incubated at 37°C ovemight. 
Delineation of individual chromosomes with DNA probes 
derived from sorted human chromosomes was done by a 
method termed chromosomal in situ suppression (CISS) 
hybridization as described (14). Briefly, biotinylated chro-
mosome 21 library DNA inserts (5 ""g/ml), DNase-digested 
human genomic DNA (200 ""g/ml), and salmon sperm DNA 
(800 ""g/ml) were combined in the hybridization solution, 
heat-denatured, and partially prehybridized for 10-30 min at 
37°C before application to a separately denatured specimen. 
Posthybridization washes, detection of hybridized probe 
by using either alkaline phosphate-conjugated avidin or fluo-
rescein isothiocyanate-conjugated avidin, and photographic 
conditions were as described (14). When probe sets contain-
ing 29 kb or less of target sequence were used, the fluorescein 
isothiocyanate detection was generally enhanced by one 
cycle of signal amplification (31). 
All quantitative analyses ofinterphase signals were carried 
out by using slides from several independent experiments, 
with more than 100 nuclei being analyzed per slide. Compar-
ison of signals in normal and trisomic sampies was done in a 
blind-study fashion. 
RESULTS 
Various combinations of cloned DNA fragments from human 
chromosome 21, previously localized to the 21q22.3 band, 
were tested for their ability to specifically label the cognate 
chromosomal region in lymphocyte metaphase spreads and 
interphase nuclei after in situ hybridization. The maximal 
amount of unique-sequence DNA in the probe set was =94 
kb; this probe set resulted in a clearly visible labeling of the 
terminal region of both chromatids of the chromosome 21 
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homologs (see Fig. IB). These signals were seen unambig-
uously and without exception in all metaphase spreads, even 
in spreads of poor quality or from prophase cells (not shown). 
In normal interphase cells, the majority (65-75%) of nuclei 
exhibited two signals (see Fig. le), 25-30% showed one 
signal, and less than 5% showed no signal (for discussion of 
signal distribution in interphase nuclei, see refs. 13-15). 
Nuclei with three signals were found only rarely «0.2%) and 
may reflect incomplete hybridization to a few tetraploid cells 
in the sampie. Similar results were obtained with probe sets 
containing 29 or 75 kb of DNA. With probe sets containing 
fewer than 20 kb of insert DNA, there were increased 
numbers of cells with less than two signals. Thus, these probe 
sets were deemed unsuitable for diagnostic purposes. How-
ever, such probes still yielded specific signals on the majority 
of chromosomes 21, even with a 6-kb single-copy DNA (see 
Fig. lA), especially when signal amplification was used. 
The usefulness of chromosome library DNA CISS hybrid-
ization (14) for detecting chromosome 21 was also evaluated. 
Chromosome 21 was specifically and entirely decorated in 
normal lymphocyte metaphase spreads, although some ad-
ditional minor binding sites were seen at or near the centro-
meric region of other acrocentric chromosomes, especially 
chromosome 13 (normal karyotype not shown; see Fig. lE). 
Suppression with additional DNA including the plasmid 
L1.26, which detects a repetitive DNA located predomi-
nantly at the centromeric region of chromosomes 13 and 21 
(32), did not efficiently suppress the minor non-21 chromo-
somal signals. Quantitative evaluation of interphase nuclei 
signals again showed a negligible portion of nuclei with three 
signals; however, a significant increase in nuclei with less 
than two signals was observed (50-60% with two signals, 35-
45% with one signal, and 5-10% without a signal). The 
numerical differences observed with the two different probes 
can be explained in part by the number of nuclei (up to one 
ofthree) that were excluded from the latter analysis because 
they exhibited larger and more diffuse signals, most likely 
from more than one chromosome that could not be resolved 
unambiguously as two separate chromosome domains in a 
two-dimensional representation. The minor cross-hybrid-
izing sites noted above presented a second experimental 
complication but did not adversely influence data interpre-
tation. 
The optimal (94 kb) plasmid pool as weil as CISS hybrid-
ization with chromosome 21 library inserts were tested 
further by using cells containing chromosome 21 aberrations. 
Both probe sets permitted a fast and unambiguous diagnosis 
of trisomy 21 in all metaphase spreads from Down syndrome 
lymphocyte cultures (see examples in Fig. 1 D and E). 
Furthermore, the quantitative distribution of hybridization 
signals in interphase nuclei ofthe same preparation, analyzed 
as described above, was similar with either type of probe 
[<5% of cells with no signal, 5-15% with one signal, 25-35% 
with two signals, and 55-65% with three signals (Fig. 1 F-J)]. 
Although the library DNA inserts gave up to 15% of four-
signal nuclei (compare Fig. 1 Fand G), most likely because 
ofthe minor binding sites on other chromosomes, the plasmid 
pool revealed only a negligible percentage ofnuclei «0.2%) 
with four signals. These results indicate that trisomy 21 can 
be detected in a diagnostically meaningful way with small 
populations of nonmitotic cells. 
Embryonic chorionic villi (CV) cells were also investigated 
with the 94-kb plasmid probe set in a case where the father 
had a reciprocal t(4;21) translocation. Hybridization to meta-
phase spreads of the CV cells showed that the translocated 
chromosome (4pter~4q33::21ql1.2~21qter) was indeed in-
herited by the fetus (see Fig. 1 Land M). The signals in the 
interphase cell nuclei (see Fig. lK) of the CV cells had a 
distribution that paralleled that of cells with anormal kary-
otype (see above), indicating a balanced representation of 
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FIG.1. Specific labeling ofhuman chromosome 21 by in situ hybridization with biotinylated DNA probe sets. (A) Plasmid pPW519-1R (6-kb 
insert) hybridized to anormal Iymphocyte metaphase spread. Signals are located on the termini of 21q [see 4' ,6-diamidino-2-phenylindole 
(DAPI)-stained chromosomes in Insel] as verified by DAPI banding (not shown). (B and C) Normal human Iymphocyte metaphase (B) and nuclei 
(C) after hybridization with the 94-kb plasmid pool probe set. The terminal band 21q22.3 is specifically labeled. (D and E) Signals on trisomy 
21 (47,+21) Iymphocyte metaphase spreads after hybridization with the 94-kb probe set (D) or chromosome 21library DNA inserts with the 
CISS hybridization (14) protocol (E). Three chromosomes 21 are entirely delineated by the Iibrary inserts; additional minor signals (see text) 
are indicated by arrowheads (also in G). (F-J) Labeling of trisomy 21 lymphocyte nuclei by the Iibrary inserts (F and G; compare with E) and 
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21q22.3 and excluding Down syndrome as a possible diag-
nosis. A small increase of nuclei with three and four signals 
(both <5%) over that of normal lymphocytes was also 
observed, probably reflecting a higher portion of tetraploid 
cells in such CV sampies. 
The diagnostic potential ofthe chromosome 21 probes was 
furt her tested by using a glioma tumor cell line, TC620, 
known to be pseudotriploid with a highly rearranged genome 
(13,15,28). The metaphase spreads revealed two apparently 
normal chromosomes 21 and one translocation chromosome 
(see Fig. 1 N and 0). Interestingly, the chromosome 21 DNA 
on the translocation chromosome labeled by the library probe 
has a size equivalent to anormal 21q region, thus suggesting 
a Robertsonian translocation event. However, fine structural 
aberrations of 21q (i.e., small deletions etc.) cannot be 
excluded by this analysis. The interphase signals seen with 
both the plasmid probe set and the library inserts were 
consistent with trisomy 21q22.3 and trisomy 21, respectively. 
Finally, we determined if the 94-kb plasmid probe set could 
be used to localize chromosome 21 DNA sequences in solid 
tissues . Fig. 2 shows the nucleus of a cortical neuron from 
"normal" human brain tissue after in situ hybridization. Both 
chromosomes 21 are clearly labeled by the probe, and they 
are located near the nucleolus; this nuclear location is con-
sistent with the fact that chromosome 21 contains a ribosomal 
gene cluster that is usually localized in the nucleolus. This 
observation suggests that these probes mayaiso prove useful 
for evaluating the frequency of chromosome 21 mosaicism in 
specific cell or tissue types. In addition, it should be of 
interest to see if the various karyotypic changes associated 
with the Down syndrome phenotype alter the normal nuclear 
topography of chromosome 21 in neuronal tissue. 
DISCUSSION 
We have demonstrated a method to rapidly detect numerical 
and structural aberrations of chromosome 21 in metaphase 
and in interphase cells. A trisomic karyotype can be diag-
nosed easily in interphase cells because the majority of the 
nuclei (55-65%) exhibit three distinct foci ofhybridization. In 
contrast, less than 0.2% of nuclei in lymphocytes with a 
disomic karyotype show three nuclear signals; interestingly, 
the percentage of such nuclei in normal CV cells was higher 
but still considerably less than 5%. In general, as few as 20-
30 cells were sufficient to unambiguously distinguish between 
disomic and trisomic cell populations. However, in view of 
the uncertainty of the level of chromosome 21 mosaicism in 
clinical sampies, the number of cells required to make an 
unambiguous diagnosis will likely be higher. Additional 
clinieal correlations will be required to establish the absolute 
number. Nevertheless, this analytical approach could allow 
the diagnosis of Down syndrome without the need to culture 
cells or to obtain metaphase spreads. 
Pools ofplasmid DNA from 21q22.3 and a "complete" set 
of DNA inserts from a chromosome 21 library were com-
pared as probes. In general, the plasmid probe set was 
superior for interphase diagnosis because smaller and more 
focal areas were labeled with improved spatial resolution. 
This probe set, whieh labels 21q distal to the centromere, also 
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FIG. 2. Visualization of 21q22.3 in a nucleus of a large neuron in 
human parietal lobe tissue. The biotinylated plasmid pool probe set 
(94 kb) was detected by the purple-colored precipitate generated by 
alkaline phosphatase (conjugated to avidin). The arrows indicate the 
two signals; " n" indicates the center of the nucleolus. 
has the particular advantage of relative insensitivity to 
interindividual pericentromeric heteromorphisms. Further-
more, unlike the library DNA inserts, there were no minor 
nonspecific hybridization signals. Eventually, removal of the 
cross-hybridizing sequences from the library DNA [e.g., as 
by subtractive hybridization (33)] could make chromosomal 
decoration from pter to qter more attractive for diagnostic 
purposes. It should also be noted that the 94-kb plasmid 
probe exhibited several types of hybridization patterns in 
interphase cells, each exhibiting subtle differences in struc-
tural detail (see Fig. 1 C and H-K). For example, in many 
GI-phase cells, each nuclear domain can be resolved as a 
doublet of closely juxtaposed signals. The variability in the 
nuclear signal patterns may reflect dynamic changes in this 
segment of euchromatie DNA that occur at different stages of 
the cell cycle or during transcriptional activation. 
Although we have used here selected plasmid clones 
containing only unique human DNA sequences, cosmid 
clones containing repetitive sequences can also be used to 
specifically label their cognate genomic region in metaphase 
and interphase cells by applying hybridization protocols like 
CISS hybridization that suppress the signal contribution of 
repetitive sequence elements (14, 34, 35). Therefore, single or 
nested sets of cosmids could be used as diagnostic tools for 
other genetic diseases in a fashion similar to that reported 
here. Trisomy of chromosomes 13, 18,21, X, and Y together 
account for the vast majority of numerical and/or structural 
chromosome abnormalities identified during prenatal karyo-
typing. With the continued development of multiple noniso-
topic probe labeling and detection systems (13,15), it should 
be possible to visualize three or more chromosomes simul-
taneously following in situ hybridization. Thus, the develop-
ment of a rapid and automated screening test to detect the 
major trisomie disorders directly in interphase cells from 
amniotic fluid or chorionic villi cells is a viable future 
objective. The analysis of specific human chromosomes by in 
situ hybridization has already been used to complement 
conventional cytogenetie studies of highly aneuploid tumor 
the 94-kb probe set (H-J; compare with D) . (K-M) Nuclei (K) and metaphase spread (M) of chorionic villi cells containing a translocation 
chromosome but showing a balanced karyotype with regard to 21q22.3, and DAPI-counterstained metaphase (L) indicating (Iower arrow) the 
terminal region of 21q, which is translocated to a B-group chromosome independently identified as chromosome 4 by banding analysis (T. 
Yang-Feng, Yale University, personal communication). (N and 0) Chromosome 21 delineated in a metaphase spread ofthe oligodendroglioma-
derived cellline TC620 by using the library inserts probe (0) and DA PI staining (N). TC620 exhibits two chromosomes 21 and one translocation 
chromosome (see N, left arrow) whose short arm contains an apparently complete 21q, suggesting a Robertsonian translocation event. Arrows 
indicate either hybridization signals or the corresponding DAPI-stained chromosome. Detection ofthe hybridized probes was with fluorescein 
isothiocyanate-conjugated avidin [the signal of the 6-kb probe (A) was amplified (31)]. Similar results were obtained when the detection was 
mediated by alkaline phosphatase-conjugated avidin (not shown). 
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lines (15), and the extension to prenatal diagnostic applica-
tions seems warranted. 
The analysis of karyotypes with translocations of chromo-
some 21 shows the usefulness of a regional probe set to 
rapidly identify and characterize even small translocations by 
unambiguous signals on metaphase chromosomes, thus cir-
cumventing an extensive analysis by high-resolution band-
ing. In contrast, the library insert probe is more suitable for 
defining the relative amount of chromosome 21 DNA that has 
been translocated. By analyzing interphase nuclei, one can 
also determine if a balanced or unbalanced number of 
chromosomal regions exists. However, the detection of a 
translocated chromosome directly in nuclei would require 
double-Iabeling techniques to identify the recipient chromo-
some to which the chromosome 21 material was translocated. 
With prior knowledge of the chromosomes in question, such 
translocation events could be assessed by measuring the 
juxtaposition of the nuclear signals (9). 
Finally, we have shown that probes containing 6 kb of 
sequence can be localized in both metaphase spreads and 
interphase cells with high efficiency. This detection sensitiv-
ity with nonisotopic reagents is similar to that achieved in 
other recent reports (36-38). The combination of nonisotopic 
in situ hybridization with DAPI or BrdUrd banding or total 
chromosome decoration with library DNA probes thus pro-
vides a simple and general approach for gene mapping. It also 
should facilitate the use of small DNA probes to rapidly 
pinpoint the breakpoints on translocation chromosomes, 
which could further aid in defining the genomic segment 
critical for Down syndrome. 
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